Loading chat...
ND SB2248
Bill
Status
1/20/2025
Primary Sponsor
Jeff Barta
Click for details
AI Summary
-
Expands step therapy protocol restrictions to cover prescription drugs for "associated conditions" of metastatic cancer (symptoms or side effects of the cancer or its treatment), in addition to the cancer itself
-
Pharmacy benefits managers and health plans cannot require step therapy when the prescribed drug is FDA-approved and either has FDA-approved indications or is supported by peer-reviewed medical literature
-
Applies only to the uniform group insurance program (public employees) for coverage periods between July 1, 2025 and June 30, 2027
-
Requires the Public Employees Retirement System to submit a bill to the 70th Legislative Assembly to potentially extend this coverage to all group and individual health insurance policies, along with a report on utilization, costs, and recommendations
-
Act expires June 30, 2027, functioning as a two-year pilot program
Legislative Description
Step therapy protocols; to provide for a report to the legislative assembly; to provide for application; and to provide an expiration date.
Last Action
Second reading, failed to pass, yeas 2 nays 45
2/7/2025